Haba Laboratories

Haba Laboratories FCF/Debt

The Free Cash Flow to Debt Ratio of Haba Laboratories (4925.T) as of Oct 21, 2026 is 97.72 %. In the previous year, Free Cash Flow to Debt Ratio was 81.61 % — a change of 19.74% (higher).

FCF/Debt

97.72 %

YoY

19.74%

Last updated:

Free Cash Flow to Debt Ratio of Haba Laboratories is 2026 97.72 % . Free Cash Flow to Debt Ratio of Haba Laboratories was 2025 81.61 % . It decreases by 19.74% higher compared to the previous year.

The Haba Laboratories FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2019
69.74 JPY
Jan 1, 2020
-7.97 JPY
Jan 1, 2021
-8.85 JPY
Jan 1, 2022
59.70 JPY
Jan 1, 2023
-11.45 JPY
Jan 1, 2024
-43.36 JPY
Jan 1, 2025
81.61 JPY
Jan 1, 2026
97.72 JPY
The Haba Laboratories FCF/Debt history
YEARFCF/DebtYoY
97.72 %+19.74%
81.61 %-288.20%
-43.36 %+278.81%
-11.45 %-119.18%
59.70 %-774.42%
-8.85 %+11.10%
-7.97 %-111.42%
69.74 %-0.88%
70.36 %+330.08%
16.36 %-52.61%
34.52 %-497.56%
-8.68 %-167.85%
12.80 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Haba Laboratories Stock analysis

What does Haba Laboratories do? HABA Laboratories, Inc. generates revenue through the development, manufacture, and sale of natural cosmetics, quasi-drugs, and nutritional supplements. The company distributes its products via wholesale to department stores and through mail order services to general customers, while also selling directly at its own retail stores. Its main business focuses on women's and men's cosmetics, targeting consumers seeking natural beauty and health solutions through both retail and direct channels. The firm's revenue streams include wholesale distribution to retailers and wholesalers, alongside direct sales at its retail stores. Products are marketed under the HABA brand, with a focus on natural ingredients for cosmetics, quasi-drugs, and nutritional supplements. The company serves both individual consumers through mail order and business clients through wholesale partnerships. HABA Laboratories' business model relies on a dual approach of B2B and B2C sales, with department stores, retailers, and wholesalers as key wholesale partners. The company's product portfolio caters to the growing demand for natural personal care items, leveraging its retail presence and mail order services to reach a broad customer base. Haba Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Haba Laboratories stock

Free Cash Flow to Debt Ratio of Haba Laboratories is 97.72 % in 2026.

Free Cash Flow to Debt Ratio of Haba Laboratories changed from 81.61 % to 97.72 %, representing a 19.74% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Haba Laboratories since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Haba Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Haba Laboratories

All Key Metrics — Haba Laboratories